Your search returned 7 results.

Results
	1.	Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivity. [electronic resource] by Lin, Amy H Burrascano, Cindy Pettersson, Par L Ibañez, Carlos E Gruber, Harry E Jolly, Douglas J Producer: 20141212 In: Journal of virology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types. [electronic resource] by Twitty, Chris G Diago, Oscar R Hogan, Daniel J Burrascano, Cindy Ibanez, Carlos E Jolly, Douglas J Ostertag, Derek Producer: 20161104 In: Human gene therapy methods vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models. [electronic resource] by Yagiz, Kader Huang, Tiffany T Lopez Espinoza, Fernando Mendoza, Daniel Ibañez, Carlos E Gruber, Harry E Jolly, Douglas J Robbins, Joan M Producer: 20170821 In: Neuro-oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models. [electronic resource] by Yagiz, Kader Rodriguez-Aguirre, Maria E Lopez Espinoza, Fernando Montellano, Tiffany T Mendoza, Daniel Mitchell, Leah A Ibanez, Carlos E Kasahara, Noriyuki Gruber, Harry E Jolly, Douglas J Robbins, Joan M Publication details: Molecular therapy oncolytics Mar 2018 In: Molecular therapy oncolytics vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids. [electronic resource] by Burnett, Ryan Ibañez, Carlos E Pettersson, Pär L Chen, Ching-I Parab, Shraddha Huang, Tiffany Robbins, Joan Bankiewicz, Krystof Aghi, Manish Logg, Christopher Kasahara, Noriyuki Pertschuk, Dan Gruber, Harry E Jolly, Douglas J Producer: 20150527 In: Molecular therapy. Methods & clinical development vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model. [electronic resource] by Huang, Tiffany T Parab, Shraddha Burnett, Ryan Diago, Oscar Ostertag, Derek Hofman, Florence M Espinoza, Fernando Lopez Martin, Bryan Ibañez, Carlos E Kasahara, Noriyuki Gruber, Harry E Pertschuk, Daniel Jolly, Douglas J Robbins, Joan M Producer: 20151022 In: Human gene therapy vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector. [electronic resource] by Ostertag, Derek Amundson, Karin K Lopez Espinoza, Fernando Martin, Bryan Buckley, Taylor Galvão da Silva, Ana Paula Lin, Amy H Valenta, David T Perez, Omar D Ibañez, Carlos E Chen, Ching-I Pettersson, Pär L Burnett, Ryan Daublebsky, Veronika Hlavaty, Juraj Gunzburg, Walter Kasahara, Noriyuki Gruber, Harry E Jolly, Douglas J Robbins, Joan M Producer: 20120515 In: Neuro-oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)